Inhibition of Aurora A in response to DNA damage

Oncogene

Volumn 25, Issue 3, 2006, Pages 338-348

  Krystyniak, A ^a   Garcia Echeverria, C ^b   Prigent, C ^c   Ferrari, S ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITÉ DE RENNES 1   (France)

Author keywords

AurA; CDK1; DNA damage; Mitosis; Phosphorylation

Indexed keywords

ALANINE; AURORA A KINASE; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CYCLIN DEPENDENT KINASE 1; DNA; DOUBLE STRANDED DNA; SERINE; SMALL INTERFERING RNA;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL LINE; DNA DAMAGE; DNA STRAND BREAKAGE; DOWNSTREAM PROCESSING; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RECONSTITUTION; GENE FUNCTION; HUMAN; HUMAN CELL; MITOSIS; MOLECULAR MECHANICS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WILD TYPE;

BASE SEQUENCE; BLOTTING, WESTERN; CDC2 PROTEIN KINASE; CELL LINE; DNA DAMAGE; DNA PRIMERS; ENZYME ACTIVATION; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; MITOSIS; MUTAGENS; PROTEIN-SERINE-THREONINE KINASES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 30944457328     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209056     Document Type: Article

References (42)

1. Andoh T, Ishida R. (1998). Biochim Biophys Acta 1400: 155-171.
2. Andresson T, Ruderman JV. (1998). EMBO J 17: 5627-5637.
3. Biggins S, Severin FF, Bhalla N, Sassoon I, Hyman AA, Murray AW. (1999). Genes Dev 13: 532-544.
4. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B et al. (1998). EMBO J 17: 3052-3065.
5. Castro A, Arlot-Bonnemains Y, Vigneron S, Labbe JC, Prigent C, Lorca T. (2002). EMBO Rep. 3: 457-462.
6. Chan CS, Botstein D. (1993). Genetics 135: 677-691.
7. Charrasse S, Carena I, Brondani V, Klempnauer KH, Ferrari S. (2000). Oncogene 19: 2986-2995.
8. Crawford DF, Piwnica-Worms H. (2001). J Biol Chem 276: 37166-37177.
9. Davies SP, Reddy H, Caivano M, Cohen P. (2000). Biochem J 351: 95-105.
10. De Azevedo WF, Leclerc S, Meijer L, Havlicek L, Strnad M, Kim SH. (1997). Eur J Biochem 243: 518-526.
11. Dutertre S, Cazales M, Quaranta M, Froment C, Trabut V, Dozier C et al. (2004). J. Cell Sci 117: 2523-2531.
12. Falck J, Lukas C, Protopopova M, Lukas J, Selivanova G, Bartek J. (2001). Oncogene 20: 5503-5510.
13. Ferrari S, Marin O, Pagano MA, Meggio F, Hess D, El-Shemerly M et al. (2005). Biochem J 390: 293-302.
14. Giet R, Prigent C. (1999). J Cell Sci 112(Part 21): 3591-3601.
15. Glover DM, Leibowitz MH, McLean DA, Parry H. (1995). Cell 81: 95-105.
16. Haydon CE, Eyers PA, Aveline-Wolf LD, Resing KA, Maller JL, Ahn NG. (2003). Mol Cell Proteomics 2: 1055-1067.
17. Hirota T, Kunitoku N, Sasayama T, Marumoto T, Zhang D, Nitta M et al. (2003). Cell 114: 585-598.
18. Honda K, Mihara H, Kato Y, Yamaguchi A, Tanaka H, Yasuda H et al. (2000). Oncogene 19: 2812-2819.
19. Joliot A, Prochiantz A. (2004). Nat Cell Biol 6: 189-196.
20. Katayama H, Zhou H, Li Q, Tatsuka M, Sen S. (2001). J Biol Chem 276: 46219-46224.
21. Kimura K, Hirano M, Kobayashi R, Hirano T. (1998). Science 282: 487-490.
22. Lengauer C, Kinzler KW, Vogelstein B. (1998). Nature 396: 643-649.
23. Littlepage LE, Ruderman JV. (2002). Genes Dev 16: 2274-2285.
24. Littlepage LE, Wu H, Andresson T, Deanehan JK, Amundadottir LT, Ruderman JV. (2002). Proc Natl Acad Sci USA 99: 15440-15445.
25. Loeb LA, Loeb KR, Anderson JP. (2003). Proc Natl Acad Sci USA 100: 776-781.
26. Marumoto T, Hirota T, Morisaki T, Kunitoku N, Zhang D, Ichikawa Y et al. (2002). Genes Cells 7: 1173-1182.
27. Marumoto T, Honda S, Hara T, Nitta M, Hirota T, Kohmura E et al. (2003). J Biol Chem 278: 51786-51795.
28. Maton G, Thibier C, Castro A, Lorca T, Prigent C, Jessus C. (2003). J Biol Chem 278: 21439-21449.
29. Mayor T, Meraldi P, Stierhof YD, Nigg EA, Fry AM. (1999). FEBS Lett 452: 92-95.
30. Meraldi P, Honda R, Nigg EA. (2002). EMBO J 21: 483-492.
31. Morris MC, Depollier J, Mery J, Heitz F, Divita G. (2001). Nat Biotechnol 19: 1173-1176.
32. Nghiem P, Park PK, Kim Y, Vaziri C, Schreiber SL. (2001). Proc Natl Acad Sci USA 98: 9092-9097.
33. Nigg EA. (2001). Nat Rev Mol Cell Biol 2: 21-32.
34. Nyberg KA, Michelson RJ, Putnam CW, Weinert TA. (2002). Am Rev Genet 36: 617-656.
35. Peters JM. (2002). Mol Cell 9: 931-943.
36. Rouse J, Jackson SP. (2002). Science 297: 547-551.
37. Sen S, Zhou H, White RA. (1997). Oncogene 14: 2195-2200.
38. Smits VA, Medema RH. (2001). Biochim Biophys Acta 1519: 1-12.
39. Stenoien DL, Sen S, Mancini MA, Brinkley BR. (2003). Cell Motil Cytoskeleton 55: 134-146.
40. Walter AO, Seghezzi W, Korver W, Sheung J, Lees E. (2000). Oncogene 19: 4906-4916.
41. Zhao B, Bower MJ, McDevitt PJ, Zhao H, Davis ST, Johanson KO et al. (2002). J Biol Chem 277: 46609-46615.
42. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A et al. (1998). Nat Genet 20: 189-193.